Why will lupus nephritis trials not fail anymore?
Rheumatology (Oxford)
.
2017 May 1;56(5):677-678.
doi: 10.1093/rheumatology/kew252.
Author
Frédéric A Houssiau
1
2
Affiliations
1
Service de Rhumatologie, Cliniques Universitaires Saint-Luc.
2
Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Bruxelles, Belgium.
PMID:
27338083
DOI:
10.1093/rheumatology/kew252
No abstract available
Publication types
Editorial
MeSH terms
Clinical Trials as Topic*
Humans
Immunosuppressive Agents / therapeutic use*
Lupus Nephritis / drug therapy*
Treatment Outcome
Substances
Immunosuppressive Agents